Colonic Diseases Clinical Trial
Official title:
The Challenge of Assessing Infectious Risk and Visceral Closure in NOTES: A Prospective Study Examining Routine Colorectal Surgery as a Model in Humans
The purpose of this study is to determine:
1. What quantity of bacteria is spilled into the abdomen during a colon resection
2. If there is a correlation between the quantity and post-operative infection
3. What intralumenal pressure is generated when testing the colonic anastomosis for air
leak
The acceptance and advancement of natural orifice translumenal endoscopic surgery (NOTES)
has forced investigators to challenge many firmly accepted surgical practices. The most
obvious one being: violating a remote hollow viscous that is uninvolved in the desired
surgical intervention. This of course brings into question (1) "How much peritoneal
contamination can be tolerated without raising infection risk?" and (2) "How will one repair
this intended visceral injury?" This study is intended to bring to light what has been done
in animal models, and further, how it will translate in to the now more important human
arena.
In this study, patients who are undergoing an elective colectomy will be investigated to
quantify what amount of peritoneal contamination is tolerated despite rare abscess formation
occurring. Subject will undergo peritoneal washings before and after colonic resection to
measure the bacterial load spilled. This data would be beneficial to support that patients
who are undergoing a NOTES procedure can and will be able to tolerate a definite quantity of
bacterial contaminate. Furthermore, by observing the exact values of peritoneal
contamination present there may be a certain level to which infectious complication are more
likely to occur. This may provide some insight in NOTES as to when patients may benefit
post-operatively from a prophylactic course of antibiotic therapy in response to their
higher than tolerable intra-peritoneal bacterial load.
The other component to this study will be to challenge how investigators are examining
closure devices in the animal model. Many researchers, including authors of this protocol,
have utilized bursting pressure as an objective test to assess the integrity of a completed
closure. Current surgical practice uses the insufflation of an endoscope or even a bulb
syringe to test for leak of a colonic anastomosis. We intend to measure the pressures that
are achieved in a clinical setting to determine the bursting pressures that are required to
assess NOTES closure and eliminate the likely unsupported value being placed on a higher
bursting pressure commonly quoted in NOTES closure studies.
;
Observational Model: Case-Only, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02503696 -
Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)
|
N/A | |
Completed |
NCT01063231 -
Evaluation of PillCamâ„¢ Colon 2 in Visualization of the Colon
|
Phase 3 | |
Terminated |
NCT01119027 -
Assessing Effectiveness of Laparoscopic Colorectal Surgical Skills
|
N/A | |
Completed |
NCT04074577 -
Computer Aided Detection, Tandem Colonoscopy Study
|
N/A | |
Not yet recruiting |
NCT04087824 -
Deep Learning Algorithm for Recognition of Colonic Segments.
|
N/A | |
Completed |
NCT03559543 -
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma
|
Phase 2 | |
Terminated |
NCT02503631 -
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
|
||
Completed |
NCT01600209 -
Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing
|
N/A | |
Completed |
NCT01260168 -
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
|
N/A | |
Completed |
NCT00604162 -
PillCamâ„¢ Colon Capsule Endoscopy (PCCE) in the Visualization of the Colon
|
Phase 3 | |
Recruiting |
NCT04598880 -
Comparison of 1 Liter PEG With Ascorbate and Sodium Picosulfate / Magnesium Citrate for High Quality Colon Cleansing
|
Phase 4 | |
Completed |
NCT01738425 -
A Clinical Phase I Study on GIC-1001 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04080843 -
Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients
|
Phase 2 | |
Terminated |
NCT04644315 -
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
|
Phase 2 | |
Completed |
NCT02291445 -
Comparing a 182mg Colon-targeted-delivery Peppermint Oil Capsule (Tempocol-ColoPulse®) and a 182mg Enteric-coated Peppermint Oil Capsule (Tempocol®), a Pharmacokinetic Study
|
Phase 2 | |
Completed |
NCT03037385 -
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03139942 -
Optical Polyp Testing for In Vivo Classification
|
N/A | |
Completed |
NCT04263818 -
Endoscopist and Endoscope Motions During Colonoscopy
|
N/A | |
Recruiting |
NCT05923918 -
A Study to Evaluate Safety and Efficacy of PBK_M2101
|
Phase 3 | |
Completed |
NCT02647866 -
Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis
|
Phase 2 |